In the BioHarmony Drug Report Database

"Preview" Icon

Mepenzolate

Cantil (mepenzolate) is a small molecule pharmaceutical. Mepenzolate was first approved as Cantil on 1982-01-01. It is used to treat peptic ulcer in the USA. It is known to target muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M3, and muscarinic acetylcholine receptor M4.

 

Trade Name

 

Cantil
 

Common Name

 

mepenzolate
 

ChEMBL ID

 

CHEMBL524004
 

Indication

 

peptic ulcer
 

Drug Class

 

Image (chem structure or protein)

Mepenzolate structure rendering